Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)
Titel:
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)
Auteur:
Aparicio, Jorge Virgili Manrique, Anna C. Capdevila, Jaume Muñoz Boza, Félix Galván, Patricia Richart, Paula Oliveres, Helena Páez, David Hernando, Jorge Serrano, Sara Vera, Ruth Hernandez-Yagüe, Xavier Gallego, Rafael Álvarez Riesco-Martinez, M. Carmen García de Albeniz, Xavier Maurel, Joan